K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 323.15 INR -0.46% Market Closed
Market Cap: 5.2B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Kilitch Drugs (India) Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kilitch Drugs (India) Ltd
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Total Receivables
â‚ą714.7m
CAGR 3-Years
48%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Receivables
â‚ą84.4B
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Receivables
â‚ą55.9B
CAGR 3-Years
17%
CAGR 5-Years
7%
CAGR 10-Years
9%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Receivables
â‚ą129.9B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
10%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Receivables
â‚ą17.9B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
3%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Receivables
â‚ą9.4B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kilitch Drugs (India) Ltd
Glance View

Market Cap
5.2B INR
Industry
Pharmaceuticals

Kilitch Drugs (India) Ltd. engages in the manufacture and sale of pharmaceuticals, medicinal chemical, and botanical products. The company is headquartered in Mumbai, Maharashtra. The company is primarily engaged in the development, manufacturing, and marketing of finished dosages. The Company’s products include parenteral solutions, effervescent, nutritional products, and medical device. Its products categories include urinary alkalizer, cephalosporins products, gastroenterology, non steroidal anti-inflammatory drugs (NSAIDs), anticonvulsant/antiepileptic, adrenergic agonist, neurotonic, muscle relaxant/stimulant, aminoglycosides, anti-infective, anti-inflammatory, anti-malarials, anti-hypertensive, anaesthetic, uterine stimulants. Its parenteral solutions include neurotonic, veterinary products, metered nasal drops, vaccines, oncology, and ophthalmic products. Its effervescent products include Roipar, Duregra, And Roivit. The firm offers nutritional products, such as Celtine. The firm also offers medical devices, such as C-Seal.

KILITCH Intrinsic Value
251.63 INR
Overvaluation 22%
Intrinsic Value
Price
K

See Also

What is Kilitch Drugs (India) Ltd's Total Receivables?
Total Receivables
714.7m INR

Based on the financial report for Sep 30, 2024, Kilitch Drugs (India) Ltd's Total Receivables amounts to 714.7m INR.

What is Kilitch Drugs (India) Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
28%

Over the last year, the Total Receivables growth was 8%. The average annual Total Receivables growth rates for Kilitch Drugs (India) Ltd have been 48% over the past three years , 28% over the past five years .

Back to Top